학술논문

Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
Document Type
Article
Source
In Lung Cancer September 2021 159:18-26
Subject
Language
ISSN
0169-5002